Lucas Guillaume, Debonnel Guy
McGill University, Department of Psychiatry, Research and Training Building, Room 207, 1033 Avenue des Pins Ouest, Montréal, Québec, H3A 1A1, Canada.
Eur J Neurosci. 2002 Sep;16(5):817-22. doi: 10.1046/j.1460-9568.2002.02150.x.
We investigated, using single-unit recordings in chloral hydrate-anaesthetized rats, the role of serotonin 4 (5-HT4) receptors in the control of dorsal raphé nucleus (DRN) 5-HT neuron activity. About one-half (36) of the 76 neurons recorded were affected by either the preferential 5-HT4 agonist cisapride (500 and 1000 micro g/kg, i.v.) or the selective 5-HT4 antagonist, GR 125487 (200- 2000 micro g/kg, i.v.). Responding neurons displayed a significantly higher mean basal firing rate (1.93 +/- 0.1 Hz) than non-responders (1.31 +/- 0.1 Hz). The firing rate of responding 5-HT neurons was enhanced dose-dependently by cisapride (+47 and +94% at 500 and 1000 micro g/kg, respectively), an effect abolished by GR 125487 (500 micro g/kg) and reduced by the 5-HT4 antagonist, SDZ 205557 (500 micro g/kg, i.v). Conversely, GR 125487 induced a dose-dependent inhibition of responders activity, which was almost completely suppressed at the dose of 2000 micro g/kg. In a separate set of experiments, the selective 5-HT4 agonist, prucalopride (500 micro g/kg, i.v), increased the firing activity (+35%) of 5-HT neurons displaying a high basal firing rate; subsequent injection of GR 125487 (500 micro g/kg, i.v.) suppressed this effect. These results indicate that 5-HT4 receptors exert both a tonic and a phasic, positive, frequency-related control on DRN 5-HT neuronal activity. The existence of such a control might open new avenues for therapeutic research in the antidepressant field.
我们在水合氯醛麻醉的大鼠中运用单单位记录技术,研究了5-羟色胺4(5-HT4)受体在控制中缝背核(DRN)5-羟色胺(5-HT)能神经元活动中的作用。在记录的76个神经元中,约一半(36个)受到选择性5-HT4激动剂西沙必利(静脉注射500和1000μg/kg)或选择性5-HT4拮抗剂GR 125487(静脉注射200 - 2000μg/kg)的影响。有反应的神经元平均基础放电频率(1.93±0.1Hz)显著高于无反应神经元(1.31±0.1Hz)。西沙必利使有反应的5-HT能神经元放电频率呈剂量依赖性增加(500和1000μg/kg时分别增加47%和94%),此效应被GR 125487(500μg/kg)消除,并被5-HT4拮抗剂SDZ 205557(静脉注射500μg/kg)减弱。相反,GR 125487对有反应神经元的活动产生剂量依赖性抑制,在2000μg/kg剂量时这种抑制几乎完全被抑制。在另一组实验中,选择性5-HT4激动剂普芦卡必利(静脉注射500μg/kg)增加了基础放电频率高的5-HT能神经元的放电活动(增加35%);随后注射GR 125487(静脉注射500μg/kg)抑制了这一效应。这些结果表明,5-HT4受体对DRN的5-HT能神经元活动发挥着一种紧张性和相位性的、正向的、与频率相关的控制作用。这种控制作用的存在可能为抗抑郁领域的治疗研究开辟新途径。